Invitations, Acquisitions, New Products, and Promotions - Analyst Notes on Cardinal Health, AmerisourceBergen, Family Dollar Stores, GNC Holdings, and Big Lots
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, March 27, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Cardinal Health, Inc. (CAH), AmerisourceBergen Corporation (ABC), Family Dollar Stores Inc. (FDO), GNC Holdings Inc. (GNC), and Big Lots Inc. (BIG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Cardinal Health, Inc. Analyst Notes
On March 24, 2014, Cardinal Health, Inc. (Cardinal Health) announced that it is inviting non-profit organizations in 18 U.S. locations and Puerto Rico to apply for grant funding to support local efforts to prevent the abuse and misuse of prescription medications. According to the Company, this grant program is intended to reduce the misuse and abuse of prescription medications among youth, college students, adults, and the elderly. Cardinal Health stated that this marks the fifth consecutive year that its Foundation's Prescription Drug Abuse and Misuse Prevention Grant Program will provide funding to help non-profit organizations raise awareness and promote education about this growing public health issue, at the local level. The full analyst notes on Cardinal Health, Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03272014/CAH/report.pdf
AmerisourceBergen Corporation Analyst Notes
On March 24, 2014, AmerisourceBergen Corporation (AmerisourceBergen) announced that it has reached a definitive agreement to acquire a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A. (Profarma), a leading pharmaceutical wholesaler in Brazil. In addition, the Company mentioned that they will establish a joint venture with Profarma for specialty distribution and services. AmerisourceBergen expects to invest a total of approximately $100 million, and the transaction to close in the quarter ending June 2014. Steven H. Collis, President and CEO of AmerisourceBergen said, "With its long-term macroeconomic growth outlook, favorable demographics, and increasing access to healthcare services and specialty pharmaceuticals, the Brazilian market affords us a tremendous opportunity to expand our international offerings. Profarma's success in the wholesale distribution, chain and independent retail, and specialty markets, combined with our expertise in specialty distribution and manufacturer services provides a compelling opportunity to shape the delivery of healthcare in Brazil." The full analyst notes on AmerisourceBergen Corporation are available to download free of charge at:
http://www.AnalystsReview.com/03272014/ABC/report.pdf
Family Dollar Stores Inc. Analyst Notes
On March 24, 2014, Family Dollar Stores Inc. (Family Dollar Stores) announced that it has named Brian D. Hancock to the position of Senior Vice President-Supply Chain. Mr. Hancock will report to Howard R. Levine, Chairman and CEO of the Company. "Since we opened our first store in 1959, our focus has been on providing our customers with great value and convenience. In today's competitive retail environment, building an efficient, end-to-end supply chain is critical to providing our customers with the compelling values they have come to rely on Family Dollar to deliver," said Chairman and CEO, Howard R. Levine. "With Brian's diverse and extensive background in merchandising, logistics and strategic planning, I know his expertise will help our team achieve our current and future growth initiatives." The full analyst notes on Family Dollar Stores Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03272014/FDO/report.pdf
GNC Holdings Inc. Analyst Notes
On March 19, 2014, GNC Holdings Inc. (GNC Holdings) announced an innovative new line of supplement superchargers called the GNC Accelerator Series. According to GNC, the Accelerator series are scientifically formulated by its experts to provide consumers with research-based performance power for all sports, training and fitness activities. Further, the Company said that the GNC Accelerator Series products make it easy for one to personalize supplementation and benefits by adding precise doses of leucine, glutamine and creatine to any powdered supplement in one's current regimen. "The GNC Accelerator Series is nothing less than a completely new approach to achieving your personal goals by customizing your supplement regimen," said Tom Dowd, Executive Vice President, Chief Merchandising Officer and General Manager for GNC. The full analyst notes on GNC Holdings Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03272014/GNC/report.pdf
Big Lots Inc. Analyst Notes
On March 24, 2014, Big Lots Inc.'s (Big Lots) stock slipped 1.45% to end the trading session at $37.47 per share. Over the past five days, Big Lots' stock has gained 3.17%, beating the Dow Jones Industrial Average which has gained 0.18% during that same period. The full analyst notes on Big Lots Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03272014/BIG/report.pdf
About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article